JG HCPCS Level II modifier: Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes
CMS terminated JG: its last date of service was Dec 31, 2024. It stays here for looking up older claims; newer services need a current code.
Official description
JGDrug or biological acquired with 340b drug pricing program discount, reported for informational purposes
Short description: 340b acquired drug
HCPCS · United States
Medicare details
The indicators CMS publishes with JG in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Added
- Jan 1, 2018
- Terminated after
- Dec 31, 2024
Where JG sits
- 1GroupHCPCS modifiers
- 2Terminated JGDrug or biological acquired with 340b drug pricing program discount, reported for informational purposes
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code JG still valid?
No. CMS terminated JG; its last date of service was Dec 31, 2024. It is listed for looking up services from before then. Use a current code for newer services.
Where is JG in the HCPCS Level II list?
JG is listed under Modifiers.
Does Medicare cover JG?
CMS lists JG’s Medicare coverage as “Carrier judgment”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside JG
All modifiersJAAdministered intravenouslyJBAdministered subcutaneouslyJCSkin substitute used as a graftJDSkin substitute not used as a graftJEAdministered via dialysateJFCompounded drugJKOne month supply or less of drug or biologicalJLThree month supply of drug or biologicalJWDrug amount discarded/not administered to any patientJZZero drug amount discarded/not administered to any patientK0Lower extremity prosthesis functional level 0 - does not have the ability or potential to ambulate or transfer safely with or without assistance and a prosthesis does not enhance…K1Lower extremity prosthesis functional level 1 - has the ability or potential to use a prosthesis for transfers or ambulation on level surfaces at fixed cadence. typical of the…